I still don’t really understand how one defines “AI-driven drug discovery”. AI is a tool that will be adapted by nearly all companies in the space, and like any technology, some will leverage it more effectively than others.
It is a good question. The thing is, AI is not going to be adopted by many. What is going to be adopted is some off-the-shelf solutions. They wont dramatically change the game. There is only a limited number of companies that are building AI platforms. Call them "OpenAIs" of biotech. Those have a chance to change the game
I still don’t really understand how one defines “AI-driven drug discovery”. AI is a tool that will be adapted by nearly all companies in the space, and like any technology, some will leverage it more effectively than others.
It is a good question. The thing is, AI is not going to be adopted by many. What is going to be adopted is some off-the-shelf solutions. They wont dramatically change the game. There is only a limited number of companies that are building AI platforms. Call them "OpenAIs" of biotech. Those have a chance to change the game